Non-motor Symptoms and Brain Dopamine Transporter Binding (NMDAT)

Turku University Hospital (TYKS)

Status: Active, not recruiting

Conditions: Parkinson Disease; Parkinsonism

Treatments: Other: DAT SPECT imaging

Study type: Observational

Funder types: Other

Identifiers

NCT02650843

T12/2014

Details and patient eligibility

About

This project aims to clarify the role non-motor symptoms in the development of Parkinson's disease (PD) and to improve diagnostics at very early stages of PD. The project involves multidimensional measures of disease biomarkers together with brain dopamine transporter (DAT) imaging with [123I]FP-CIT single photon emission computed tomography (SPECT).

Enrollment: 455 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Male or Female
• Age 18-100 years
• Referred for clinical DAT SPECT in Turku or Helsinki

Trial design

455 participants in 1 patient group

Patients with parkinsonism

Description:

Patients with parkinsonism that are referred for DAT SPECT imaging in Turku University Hospital, Finland or Helsinki University Hospital, Finland

Treatment:

Other: DAT SPECT imaging